{
    "2020-03-19": [
        [
            {
                "time": "",
                "original_text": "凯莱英回复：高瓴资本有助于公司CDMO领域发展",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "高瓴资本",
                        "CDMO",
                        "发展"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2020年医药行业格局如何？投资者推荐三大逻辑",
                "features": {
                    "keywords": [
                        "2020年",
                        "医药行业",
                        "格局",
                        "投资者",
                        "三大逻辑"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "投资"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}